http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-35930-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C209-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C35-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-38
filingDate 1971-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1976-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-35930-B1
titleOfInvention Amines and a process for the manufacture thereof
abstract 1307458 1,7-Dimethyl-2-norbornanamines F HOFFMANN-LA ROCHE & CO KG 16 July 1971 [17 July 1970] 33476/71 Heading C2C Novel 1,7-dimethyl-2-norbornanamines of the general formula wherein R is a C 1-6 alkyl or optionally substituted phenyl group and R<SP>1</SP> is a C 1-6 alkyl group, provided that at least one of R and R<SP>1</SP> is a methyl group, and acid addition salts thereof are prepared by (a) reducing an imine of the general formula wherein R<SP>2</SP> is a hydrogen atom or hydroxy group, or (b) hydrolysing an amine derivative of the general formula wherein R<SP>3</SP> is a hydrolytically-removable group, and, if desired, resolving a stereoisomer or diastereomer mixture obtained and also, if desired, converting a base obtained to an acid addition salt thereof. N - [4 - (Phenyl or p-chlorophenyl) - 2 - exobornyl]-acetamide is prepared by reaction of 2- (phenyl or p-chlorophenyl)-borneol, respectively, with acetonitrile in the presence of glacial acetic acid and conc. H 2 SO 4 . N-(4-Propyl-2-exobornyl)-acetamide is prepared by reaction of 2- propylidene-camphane with acetonitrile in the presence of glacial acetic acid and cone. H 2 SO 4 . N (1,4,7;7 - Tetramethyl - 2 - exo - norbornyl) acetamide is prepared by reaction of 1-methylcamphene with acetonitrile in the presence of cone. H 2 SO 4 . N - [4 - (p - Nitrophenyl) - 2 - exobornyl] - acetamide is prepared by nitration of N - (4 - phenyl - 2 - exo - bornyl) - acetamide. N - (1,4,7,7 - Tetramethyl - 2 - exo - - norbornyl). thiocarbamic acid S-methyl ester is prepared by reaction of 1- methyl -camphene with methyl thiocyanate in the presence of glacial acetic acid and cone. H 2 SO 4 N-[4-(p-Methoxyphenyl)-2- exo.bornyl].acetamide is prepared by reaction of 2 - (p - methoxyphenyl) - bornylene - (2.) with acetonitrile in the presence of glacial acetic acid and conc. H 2 SO 4 . 2-(p-.Chlorophenyl).borneol is prepared by reaction of 4-bromo-chlorobenzene, magnesium and camphor in ether, followed by treatment of the resulting complex with ammonium chloride solution. The 1,7 -dimethyl -2-norbornanamines of the first general formula above wherein R<SP>1</SP> is a methyl group can be reacted with 1,4-naphthoquinones of the general formula wherein X<SP>1</SP> is a hydrogen or halogen atom or a C 1-6 alkoxy group and R<SP>X</SP> is a leaving atom or group, to give arnosebicidal and baoteriostatic 2.- bornylamino - 1,4-naphthoquinones of the general formula Pharmaceutical compositions having virucidal and anticataleptic activity comprise, as active ingredient, a 1,7-dimethyl-2-norbornanamine of the first general formula above or a pharmaceutically acceptable acid addition salt thereof together with a pharmaceutical carrier.n[GB1307458A]
priorityDate 1970-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85779551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423531022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410441668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6552009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420283665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430751356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415806868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424480116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451203358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID179359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55291040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18406420

Total number of triples: 52.